State of the art: leadless ventricular pacing
ÖKG · 2019 · Austria
Source and licence
- Authors
- C Steinwender, P Lercher, C Schukro et al.
- Title
- State of the art: leadless ventricular pacing
- Journal
- Journal of Interventional Cardiac Electrophysiology, 2019
- Licence
- CC BY 4.0
- Changes
- Verbatim excerpts; formatting adapted
Full text retrieved 2026-10-27 from Europe PMC · PMC7036055
Licence statement of the original publication
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
This page reproduces excerpts of the original publication; the original is authoritative. It has not been reviewed by a physician, does not state a recommendation of Medelix and does not replace medical advice. The guideline may have been updated since.
Open the original publication →Full text on Europe PMC
Recommendations
We found no explicitly labelled recommendations in this publication; its recommendations are in the running text of the original.
Abstract
Background: Cardiac pacing has been shown to improve quality of life and prognosis of patients with bradycardia for almost 60 years. The latest innovation in pacemaker therapy was miniaturization of generators to allow leadless pacing directly in the right ventricle. There is a long history and extensive experience of leadless ventricular pacing in Austria. However, no recommendations of national or international societies for indications and implantation of leadless opposed to transvenous pacing systems have been published so far.
Results: A national expert panel of skilled implanters gives an overview on the two utilized leadless cardiac pacing systems and highlights clinical advantages as well as current knowledge of performance and complication rates of leadless pacing. Furthermore, a national consensus for Austria is presented, based on recent studies and current know-how, specifically including indications for leadless pacing, management of infection, suggestions for qualification, and training of the operators and technical standards.
Conclusions: Leadless pacing systems can be implanted successfully with a low complication rate, if suggestions for indications and technical requirements are followed.
Condensed abstract: An overview of the two utilized leadless cardiac pacing systems is given, specifically highlighting clinical advantages as well as current knowledge of performance and complication rates. Furthermore, a national consensus for Austria is presented, specifically including indications for leadless pacing, management of infection, and suggestions for qualification and technical standards.
Contents of the original publication
The section headings of the original.
- Background: current clinical evidence for leadless pacing
- Nanostim® leadless cardiac pacemaker (LCP)
- Micra® transcatheter pacing system (TPS)
- Comparison of leadless versus transvenous PM systems
- Magnetic resonance imaging (MRI) compatibility of leadless pacemaker systems
- Management of device infections: advantages of leadless pacers
- A national consensus for indications of leadless pacing in Austria
- Pacing indications based on the underlying arrhythmia
- Clinical circumstances that favor either LP or transvenous PM
- Standards for implantation and surgical management of leadless pacing
- Qualification and technical standards for implantation
- Surgical management
- Conclusion
- Contributor Information
A question about this guideline?
Medelix answers clinical questions from guidelines and studies – every statement with its source.
Are you the rights holder and object to this reproduction? Write to contact@medelix.ai and we will take the page down promptly. Imprint